Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
1001 Flynn Road , Camarillo, CA, 93012, US
Collaboration targets lower-dose therapies for genetic muscle disease and in vivo cell therapy.
By: Charlie Sternberg
Margin compression, tariff exposure, and supplier consolidation are piling pressure on contract manufacturers. But single-use technology redrew the competitive landscape and a second wave in cell and gene therapy is doing it again.
By: Dan Stanton
Biotech companies partner to develop low-dose, targeted AAV gene therapies for cardiac disease.
Catalent to support gene therapy manufacturing for SPG50 and other pipeline programs.
Addresses manufacturing challenges related to scalability, cost of goods and process consistency as gene therapy programs move toward commercialization.
Epicrispr’s investigational gene therapy, EPI-321, is a treatment for facioscapulohumeral muscular dystrophy.
By: Patrick Lavery
To create US-APAC manufacturing corridor, enabling local production for global clinical trials.
By: Kristin Brooks
Forge Biologics will provide process development and manufacturing services to support gene therapy for ultrarare disease.
Will apply the AAV Curator Platform to manufacture clinical grade AAV for Drake Rayden Foundation for the treatment of nonketotic hyperglycinemia.
Potency assays are central to proving a therapy activity and safety.
Released By Solvias
Notable pitfalls in the cell and gene therapy space can be addressed with specific aspects of digitalization.
By: Anshul Mangal
Pitcher offers experience scaling cell and gene therapy manufacturing operations and aligning them with client and patient needs.
The program aims to expedite the development of technologies and life-changing therapies for patients in need.
AGC Biologics to provide GMP manufacturing for AAVantgarde’s two novel candidates designed to address progressive and irreversible vision loss.
Expands the company’s nationwide network supporting cell and gene therapy (CGT) innovation.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
